Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGO2 | Q9UKV8 | 1/20 | 0.97 |
| ▸ | C9 | P02748 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.43 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.43 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5992669 | 0.99 | AGO2 (1.00) | AGO2C9KDM4EALDH1A1HPGD | |
| SCHEMBL2833452 | 0.67 | KDM4E (0.62) | AGO2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL1649282 | 0.67 | ALDH1A1 (0.62) | AGO2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL9755165 | 0.67 | KDM4E (0.67) | AGO2C9KDM4EALDH1A1HPGD | |
| SCHEMBL14381820 | 0.66 | KDM4E (0.61) | AGO2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL10370338 | 0.64 | KDM4E (0.62) | AGO2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL11233617 | 0.63 | KDM4E (0.66) | KDM4EALDH1A1HPGDHSD17B10TDP1 | |
| SCHEMBL11217868 | 0.63 | KDM4E (0.66) | KDM4EALDH1A1HPGDHSD17B10TDP1 | |
| SCHEMBL8428483 | 0.62 | CA1 (0.58) | AGO2KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL658651 | 0.62 | KDM4E (0.56) | AGO2KDM4EALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240277742-A1 | TRANSLATION INHIBITOR WITHOUT OCCUPYING RIBOSOME RESOURCES AS ANTI-TUMOR DRUG | CHI BIOTECH CO., LTD. (CN) | 2024-08-22 | — | — | US | disclosed |
| WO-2023138011-A1 | TRANSLATION INHIBITOR NOT OCCUPYING RIBOSOME RESOURCE AS ANTITUMOR DRUG | 深圳承启生物科技有限公司 | 2023-07-27 | — | — | WO | disclosed |
| CN-114404400-A | Translation inhibitor without occupying ribosome resource as antitumor drug | 深圳承启生物科技有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-10589003-B2 | Methods for coating surfaces with antimicrobial agents | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-03-17 | — | — | US | disclosed |
| US-20180303977-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-10-25 | — | — | US | disclosed |
| CN-104560461-A | Washing agent for mercury-polluted building wastes | YANTAI SHUNLONG CHEMICAL TECHNOLOGY CO LTD | 2015-04-29 | — | — | CN | disclosed |
| US-8053475-B2 | Preparation of the formaurindikarboxyl acid base and its derivations and use | Vyzkumny Ustav Zivocisne Vyroby, V.V.I. (CZ) | 2011-11-08 | — | — | US | disclosed |
| US-8030353-B2 | Preparation of the formaurindicarboxylic acid base and its derivations and use | Vyzkumny Ustav Zivocisne Vyroby, V.V.I. (CZ) | 2011-10-04 | — | — | US | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-20110009490-A1 | PREPARATION OF THE FORMAURINDIKARBOXYL ACID BASE AND ITS DERIVATIONS AND USE | KLEIN PAVEL | 2011-01-13 | — | — | US | disclosed |
| US-20090275661-A1 | PREPARATION OF THE FORMAURINDICARBOXYLIC ACID BASE AND ITS DERIVATIONS AND USE | VYKUMNY USTAV ZIVOCISNE VYROBY, V.V.I. (CZ) | 2009-11-05 | — | — | US | disclosed |
| US-20080183152-A1 | MEDICAL DEVICES WITH BROAD SPECTRUM ANTIMICROBIAL ACTIVITY | RAAD ISSAM | 2008-07-31 | — | — | US | disclosed |
| US-20070154621-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2007-07-05 | — | — | US | disclosed |
| US-20050197634-A1 | Methods for coating and impregnating medical devices with antiseptic compositions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
| US-5652093-A | Analogues of reporter groups as background reducers in binding assays | APROGENEX, INC. (US) | 1997-07-29 | — | — | US | disclosed |
| US-5501952-A | Analogues of reporter groups as background reducers in hybridization assays | APROGENEX, INC. (US) | 1996-03-26 | — | — | US | disclosed |
| EP-0662152-A1 | ENRICHING AND IDENTYFYING FETAL CELLS IN MATERNAL BLOOD FOR IN SITU HYBRIDIZATION | APROGENEX, INC. (US) | 1995-07-12 | — | — | EP | disclosed |
| WO-1995003431-A1 | ENRICHING AND IDENTIFYING FETAL CELLS IN MATERNAL BLOOD FOR IN SITU HYBRIDIZATION | APROGENEX, INC. (US) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995002699-A1 | ANALOGUES OF REPORTER GROUPS AS BACKGROUNG REDUCERS IN HYBRIDIZATION ASSAYS | APROGENEX, INC. (US) | 1995-01-26 | — | — | WO | disclosed |
| WO-1994002646-A1 | ENRICHING AND IDENTYFYING FETAL CELLS IN MATERNAL BLOOD FOR IN SITU HYBRIDIZATION | APROGENEX INC. (US) | 1994-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240277742-A1 | TRANSLATION INHIBITOR WITHOUT OCCUPYING RIBOSOME RESOURCES AS ANTI-TUMOR DRUG | RACK1, RPL30, RRBP1 | AGO2 284/4885C9 4860/4885KDM4E 1039/4885 |
| US-10589003-B2 | Methods for coating surfaces with antimicrobial agents | CUTA, CD63, CDC37 | AGO2 3843/4885C9 167/4885KDM4E 3147/4885 |
| US-20090275661-A1 | PREPARATION OF THE FORMAURINDICARBOXYLIC ACID BASE AND ITS DERIVATIONS AND USE | ATIC, ASS1, ALDH7A1 | AGO2 4297/4885C9 851/4885KDM4E 2944/4885 |
| US-20110009490-A1 | PREPARATION OF THE FORMAURINDIKARBOXYL ACID BASE AND ITS DERIVATIONS AND USE | ATIC, ASS1, F7 | AGO2 3875/4885C9 2031/4885KDM4E 2270/4885 |
| US-20180303977-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | CUTA, CD63, CDC37 | AGO2 3843/4885C9 167/4885KDM4E 3147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.